We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > NMPA Approval

News List

First Generic Drugs Approved in China in 2022 Zhulikou/PharmaSources
February 15, 2023
List of the First Generic Drugs Approved in China in 2022
Weekly Pharma News Review | PharmaSources.com (April 11 to 15) Yefenghong
April 20, 2022
The sharp crushing in the stock prices of Chinese vaccine leader companies Zhifei Biological and Wantai Biological is the most-watched news this week.
Weekly Pharma News Review | PharmaSources.com （April.4th-April.8th） PharmaSources.com
April 12, 2022
This week, the release of Phase III clinical data for treating outpatients infected with mild and moderate COVID-19 with Kintor Pharmaceuticals' proxalutamide sparked an intense interest. The pharma news review of this week covers a total of 18 pieces of
JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in China prnasia
September 13, 2021
SHANGHAI, Sept. 6, 2021 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products